Merrimack Pharm (MACK) Posts Narrower than Expected Q2 Loss of 22c/Share

August 10, 2012 9:38 AM EDT Send to a Friend

Merrimack Pharm (NASDAQ: MACK) reported Q2 EPS of ($0.22), $0.05 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Merrimack Pharm (MACK) Posts Narrower than Expected Q2 Loss of 22c/Share

Member Login

Free News Feed